Prelude Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-155,541
Closed -$1.59M 1562
2022
Q4
$1.59M Hold
155,541
0.08% 259
2022
Q3
$1.55M Hold
155,541
0.06% 291
2022
Q2
$1.53M Hold
155,541
0.04% 378
2022
Q1
$1.53M Buy
+155,541
New +$1.53M 0.04% 444

Other funds holding PEPL

Prelude Capital Management's PEPL Position: Q1 2023 in Review

Prelude Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 155,541 shares — an estimated $1.59M sold.

Prelude Capital Management first reported a position in PEPL in Q1 2022 and held it in 4 quarters. The position peaked at $1.59M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Prelude Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 155,541 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $1.59M.
  • Prelude Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
  • Prelude Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $1.59M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.